SLC22A2 and renal carcinoma: Additionally, in renal carcinoma cells, HDAC7 and HDAC9 impair the enrichment of H3K18ac and H3K27ac modifications in the OCT2 promoter, leading to the transcriptional repression of OCT2 [45,46].